Nivolumab (anti-PD-1) Nivolumab 946414-94-4
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Name |
Nivolumab (anti-PD-1) |
CAS NO. |
946414-94-4 |
Type |
Whole antibody |
Source |
Human |
Target |
PD-1 |
Clone |
Monoclone |
Molecular Weight |
146 kDa |
Formula |
C6362H9862N1712O1995S42 |
Antibody Form |
Purified immunoglobulin |
Physical Form |
Solution |
Grade Standard |
Medicine Grade |
Place of Origin |
China(Mainland) |
Storage |
-70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Nivolumab is a fully human IgG4 antibody targeting the immune checkpoint programmed death receptor-1 (PD-1).
For research use only. Not for use in humans.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View